RecruitingPhase 1NCT05018845

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Chronic Kidney Disease.


Sponsor

The Foundation for Orthopaedics and Regenerative Medicine

Enrollment

20 participants

Start Date

Nov 6, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Chronic Kidney Disease.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study tests the safety of giving people with chronic kidney disease (CKD) stem cells grown from umbilical cord tissue via an IV infusion. The goal is to see if this cell therapy is safe and potentially slows kidney damage. **You may be eligible if...** - You have been diagnosed with chronic kidney disease - You understand the study and are willing to sign a consent form **You may NOT be eligible if...** - You have an active infection - You have active cancer - You have severe failure of multiple organs - You are pregnant - You have significant abnormal lab results that pose a safety risk - You have active drug or substance addiction - You are a pre-menopausal woman not using contraception - You previously received a stem cell transplant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALAlloRx

cultured allogeneic adult umbilical cord derived mesenchymal stem cells


Locations(1)

Medical Surgical Associates Center

St John's, Antigua and Barbuda

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05018845


Related Trials